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ess: vandanad@woolcocSummary A review of previous research suggests increased probability of the
prevalence of anxiety disorders, and particularly panic disorder and panic attacks in
patients with asthma, as compared to a normal population. Research also indicates
significant levels of co-morbidity between asthma and anxiety as measured on
dimensional scales of anxiety and panic. Clinical anxiety and panic manifestations
affect symptom perception and asthma management through the effects of anxiety
symptoms such as hyperventilation, and indirectly through self-management
behavior and physician response. However, there is limited data on the impact of
anxiety co-morbidity on asthma quality of life. Some studies indicate that individuals
with co-morbid asthma and anxiety or panic report worse asthma quality of life both
in general and in relation to their symptomatology, being limited in their daily
activities, in response to environmental stimuli and in regard to feelings of
emotional distress. Cognitive-behavioral therapy (CBT) is an effective and
empirically supported treatment of choice for anxiety disorders and panic attacks.
However, standard CBT protocols for anxiety and panic may need to be specifically
targeted at improving asthma outcomes. Also, asthma research literature is lacking
in randomized controlled trials applying CBT to patients with co-morbid asthma and
clinical anxiety manifestations. Trials evaluating CBT interventions in individuals
with clinical anxiety manifestations and asthma may provide evidence of these
interventions as an effective adjunct to improve asthma management and control.
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Two recent reviews1,2 of the literature have
described an increased rates of psychological co-
morbidity ranging from anxiety and panic symptoms
to anxiety disorders in adults with asthma. This
psychological co-morbidity is likely to impact on
asthma outcome and quality of life.2 Innate
biological factors may interact with psychological
variables playing an important role in the way the
patients adapt to or react to asthma symptoms.3
This review aims to take the reader through the
published research in the area of co-morbid anxiety
disorders and clinical manifestations of anxiety and
panic symptoms in adult asthma, and the impact
of this co-morbidity on asthma outcome and
specifically asthma-related quality of life. Further,
this review discusses current evidence and the
theoretical possibilities that may explain this co-
morbidity and explores treatment options using
cognitive-behavioral interventions. The paper high-
lights these various aspects of research and
suggests implications for policy and further re-
search. It also identifies implications for the clinical
practice of respiratory physicians, general practi-
tioners, psychologists and allied health profes-
sionals, involved in the care of patients with
asthma. The review advocates a holistic approach
to the patient and emphasizes the treatment of
‘‘the patient with asthma’’ as opposed to treat-
ment of ‘‘the asthma.’’
We completed a literature review using MEDLINE
by pairing the word ‘‘asthma’’ with the following
words: anxiety OR panic OR asthma quality-of-life
OR cognitive behavioral interventions. Bibliogra-
phies of identified articles were hand searched foradditional references not identified through the
search strategies. Key authors in the field were
searched for additional references and similar
articles were identified from the search functions
of PUBMED. We limited the search strategy to
include articles that (1) were English-language only
(2) adult samples with a minimum age X18 years
AND EITHER (a) assessed prevalence of anxiety
disorders and symptoms in patients with asthma
AND/OR (b) assessed the impact of anxiety and
panic on various asthma outcome measures includ-
ing asthma quality-of-life AND/OR (c) addressed
the role of cognitive behavioral interventions in
patients with co-morbid asthma and anxiety/panic.
We adopted a narrative format of presentation
for this review, within a systematic framework,
given the heterogeneity of anxiety constructs
ranging from anxiety symptoms to anxiety disor-
ders, as well as the multiple end points of asthma
outcome, in the available literature.
Epidemiology of co-morbid asthma and
anxiety/panic
Asthma and clinical anxiety disorders
Anxiety disorders are diagnosed clinically on a
categorical scale (diagnosis/no diagnosis) based,
for example, on the criteria of the Diagnostic and
Statistical Manual of Mental Disorders-Fourth Edi-
tion Text Revision (DSM-IV-TR).4 In this section, we
review research relating asthma to anxiety dis-
orders diagnosed categorically; in the next section
we review the relationship between asthma and
anxiety measured symptomatically.
ARTICLE IN PRESS
V.M. Deshmukh et al.196Previous research indicates an elevated preva-
lence of generalized anxiety disorder, panic dis-
order and elevated rates of panic attacks in clinical
samples and community samples of patients with
asthma.1,5–11 A recent comprehensive study in
Germany determined the association between
asthma and mental disorders in a large community
sample (N ¼ 7124) of adults aged 18–65.12 The
study systematically assessed participants with
physician-diagnosed asthma, for anxiety disorders,
using a structured interview. The study reported
that asthma was associated with a significantly
increased likelihood of any anxiety disorder, panic
disorder and panic attacks (see Table 1).
Panic attacks are characterized by a period of
intense fear, developing abruptly and reaching a
peak within 10min, with any four of the following
symptoms: Shortness of breath, choking sensations,
chest pain or discomfort, dizziness, abdominal
distress or nausea, derealization or depersonaliza-
tion, rapid heart rate, palpitations, sweating, hot
flushes or chills, shaking or trembling, fear of losing
control or going crazy, fear of dying. Panic disorder
is characterized by recurrent panic attacks with at
least a month of anticipatory anxiety of having a
panic attack or change in behavior (e.g. avoidance)
related to the attack.4
A higher prevalence of panic attacks has been
reported in other clinical and community samples
of individuals with a diagnosis asthma.6,8,9,11,13,14
Cross-sectional studies have found an association
between self-reported asthma and panic attacks
(OR ¼ 5.88 (95% CI, 2.21, 15.62)), N ¼ 2768).8 In a
primary care sample of 998 adults, where 176
adults had physician-diagnosed asthma, the asso-
ciation between asthma and panic attacks re-
mained significant (OR ¼ 1.7 (95% CI, 1.1, 2.6)),Table 1 The prevalence of anxiety disorders in a comm
Current severe asthma
(the past four weeks)
Any anxiety
disorder
OR 2.65; 95% CI,
1.35–5.18
Panic disorder OR 4.61; 95% CI,
1.09–9.4
Panic attacks OR 4.12; 95% CI,
1.32–12.8
Generalized
anxiety disorder
Specific phobia OR 4.78; 95% CI,
2.35–4.05
Social phobia
Note: OR ¼ odds ratio; CI ¼ confidence interval.after controlling for sociodemographic factors and
other mental disorders.10 Population studies based
on self-reports have also found a significant
association (OR ¼ 1.7 (95% CI, 1.2, 2.4)), between
respiratory disease and panic attacks after adjust-
ing for demographic characteristics, comorbid
disorders and physical co-morbidity.15 Other stu-
dies16–18 have also shown a higher prevalence of
panic disorder in clinic samples of individuals with
asthma and authors19,20 estimate that 6–38% of
adults with asthma meet the diagnostic criteria for
panic disorder as compared to 1–4% in the popula-
tion at large.Theoretical possibilities
Given the unpredictable and occasionally life-
threatening nature of a disorder like asthma, the
high prevalence of panic disorder and panic attacks
in individuals with asthma over and above that in a
population without asthma, is unsurprising. Some
of the theories proposed to explain this co-
morbidity include the dyspnea-fear theory attrib-
uted to the somatic effects of hyperventilation,21
theory of abnormally sensitive carbon dioxide
receptors in the central nervous system and
abnormal ‘‘suffocation detectors’’.22 Other the-
ories point to the fact that unpredictable and at
times uncontrollable dyspnoea maybe a significant
etiologic factor in panic disorder.23,24 Adrenergic-
agonists, theophylline and other steroid medica-
tions, used in asthma management, have also been
implicated in provoking anxiety.5,25,26
Other authors have suggested common genetic
influences and common environmental risk factors
like cigarette smoking, low socioeconomic status orunity sample (N ¼ 7124; Goodwin7).
Lifetime non-
severe asthma
Lifetime severe
asthma
OR 1.51; 95% CI,
1.0–2.32
OR 2.09; 95% CI,
1.3–3.36
OR 2.61; 95% CI,
1.29–5.25
OR 2.84; 95% CI,
1.66–4.89
OR 5.51; 95% CI,
2.29–13.22
OR 2.93; 95% CI,
1.71–5.0
OR 3.28; 95% CI,
1.42–7.59
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increased co-morbidity. Some authors have sug-
gested a selection bias as an explanation for this
high association between asthma and panic dis-
order. They indicate that comparable prevalence
rates (16%) have been reported in hospitalized
patients with chronic pain.27 Other studies of
patients with chronic illnesses like hypertension
and diabetes mellitus have also found comparable
prevalence rates of anxiety manifestations in their
samples.28 However, a recent prospective commu-
nity study followed a cohort of 591 adults with
asthma for 20 years. The results of the study
indicate bidirectional longitudinal associations be-
tween panic and asthma and the authors suggest a
dose response type of relationship11 where active
asthma predicted subsequent panic disorder
(OR ¼ 4.5 (95% CI, 1.1, 20.1)), and the presence
of panic disorder predicted subsequent asthma
activity (OR ¼ 6.3 (95% CI, 2.8, 14.0)), even though
gender, smoking and socioeconomic status were
confounders. In conclusion, recent literature does
suggest increased likelihood for anxiety disorders,
and particularly panic disorder and panic attacks in
patients with asthma, as compared to a normal
population.Asthma and other constructs of anxiety
Previous research also indicates significant levels of
co-morbidity between asthma and anxiety as
measured on dimensional scales of anxiety and
panic.29,30 These measures include, among others,
the Hospital Anxiety and Depression Inventory
(HADS)31 and the Spielberg’s State Trait Anxiety
Inventory (STAI).32
A study comparing psychological profiles of
patients and healthy controls suggested that
anxiety symptoms, as measured by the STAI, were
more frequently associated with a diagnosis of
asthma when compared to patients with chronic
viral hepatitis or healthy controls.29 Similarly, a
large Australian population study33 of 6609 adults
suggested that patients with asthma (n ¼ 834)
demonstrated a higher prevalence of psychological
distress (17.9%), as compared to individuals with no
diagnosis of asthma (12.2%). Diagnosed mental
health conditions were significantly more common
in patients with asthma (16.2%) as compared to
those individuals without asthma (10.8%). Another
Australian study34 found a prevalence of anxiety
symptoms (a significant score of 8 or more than 8 on
the HADS), in 40% of the clinic and research
volunteer sample of patients with asthma.However, in a Swedish population sample of 715
adults,35 there was no evidence that those diag-
nosed with asthma had more anxiety or depression,
than those individuals with no diagnosis of asthma.
Despite this contradiction, individuals with asthma
did demonstrate a significant association between
reported respiratory symptoms and anxiety symp-
toms as measured by the HADS. Accordingly,
anxiety and panic symptoms may exist, without
being classified as a disorder and may influence the
experience and behavior of an individual with
asthma and affect symptom perception and
asthma outcome.2,36 However, it cannot be sug-
gested that asthma has a higher association with
anxiety manifestations when compared to other
chronic illnesses including diabetes mellitus and
hypertension.37–44The impact of anxiety and panic on
asthma outcome
Anxiety compromises asthma outcome
Current evidence
The following research focuses on the role of anxiety
symptoms and panic fears and anxiety disorders on
various asthma outcomes. Some researchers45 have
reported an increased subjective perception of
shortness of breath in anxious individuals with
asthma even in the absence of any objectively
measured change in airway obstruction. This may
lead to an increased use of asthma medication for
what may well be anxiety symptoms.46 Moreover, the
medications most often used to treat anxiety and
panic (i.e., benzodiazepines) can affect respiratory
symptoms and clinical findings.2,26,47
The effects of panic-fear on the course of asthma
are well documented. Important aspects of this
research describes the subjective symptomatology
of asthma, and defines a symptom category,
delineated as panic-fear.48 The reported frequency
of panic-fear symptoms has been related to
measures of medical intractability and ‘‘difficult
asthma’’ such as: more intensive steroid regimen
prescriptions49; excessive use of as-needed medi-
cation50; more frequent hospital readmissions51;
and longer hospitalizations.52 These effects are
often independent of objectively measured pul-
monary impairment.50,53
Two types of panic-fear have been delineated in
the literature: panic-fear in response to the
symptoms of asthma, termed illness-specific
panic-fear and measured by the Asthma Symptom
Checklist, and a more generalized panic-fear
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Inventory), which is believed to reflect a stable
personality trait.5 Extremely high illness-specific
panic-fear leads to overuse of as needed medication,
and is associated with maladaptive and disruptive
anxiety during an asthma attack.54 Also, as Kinsman
and colleagues have pointed out, high illness specific
panic-fear can lead to hyperventilation, potentially
worsening asthma exacerbations through hyperven-
tilation induced bronchoconstriction.54
Specific psychological characteristics like illness
specific panic-fear, as compared to more general
asthma symptoms like breathlessness, character-
ized high emergency room attendees, in a sample
of 30 adult patients with asthma.55 All these
patients had made two or more unscheduled
emergency room visits for asthma exacerbations
over the 1-year study period of an earlier study.
Anxiety symptoms predicted high illness specific
panic-fear suggesting an indirect effect with an
increase in emergency room visits.
High generalized panic-fear can also impact
negatively on the course of asthma and the
potential benefits of self-management education.
High generalized panic-fear is characterized by
high anxiety, helplessness, and dependence in
response to a variety of situations beyond those
just related to breathing difficulties.54 Further-
more, high generalized panic-fear is associated
with worse medical outcome for asthmatics,
including longer and more frequent hospitaliza-
tions. Generalized panic-fear scores are indepen-
dent of objective medical indicators and highly
stable across several months of intensive in-patient
medical treatment.51,56
In summary, the studies described here reflect how
panic and anxiety adversely influences asthma
directly through the effects of panic symptoms
(e.g., hyperventilation), and indirectly through
patient behavior (e.g., overuse of medications,
self-management behavior) and physician response.
Often studies have shown that these responses have
been independent of the degree of objective
pulmonary impairment or have been significant
despite controlling for pulmonary impairment.5,55
Theoretical possibilities
Patients with anxiety and panic symptoms can
hyperventilate and this hyperventilatory response
may trigger an asthma attack or worsen a current
asthma attack. This could be related to cooling of
the airways and related bronchoconstriction57 or
bronchoconstriction due to vagal mediation.58
Anxiety symptoms characterized by prominent
respiratory symptoms (breathlessness, choking or
smothering sensations, and chest pain), may con-fuse the patient appearing to be symptoms of an
asthma attack, and may confuse the clinician when
interpreting their cause. Further, the co-existence
of asthma and anxiety/panic symptoms may make
their discrimination challenging for both patients
and their physicians.19
Anxiety and panic may also lead to phobic
avoidance of situations which can lead to signifi-
cant levels of personal handicap with social and
functional restriction, much greater than the
objectively measured physiologic level of impair-
ment.3 Anxiety symptoms also influence preventa-
tive behavior and attitude towards the illness and
its treatment and have been associated with poorly
controlled asthma and non-adherence to steroids.59
In conclusion, the relationship between respira-
tory symptoms and the state of an individual’s
asthma is complex and involves other psychosocial
factors.60 It is important for a treating physician
who is trying to achieve asthma control to be aware
that in some patients the answer may lie, not in
stepping up asthma medication, but in considering
the patient’s psychological characteristics. How-
ever, the heterogeneity of the anxiety constructs
ranging from anxiety and panic symptoms to
anxiety disorders, in the literature, as well as the
diversity of asthma outcome indicators does high-
light the need for common constructs and outcome
indicators, facilitating a more systematic review,
analysis and assessment of the impact of anxiety
manifestations.The impact of anxiety and panic on asthma
quality of life
Current evidence
There is limited data on the impact of anxiety co-
morbidity on functional status and asthma quality
of life.1 Quality of life remains an important
outcome measure because well-controlled or stable
asthma may not be equivalent to well-being of the
patient.61
Quality of life can be assessed as two different
constructs. Generic health-related quality of life
focuses on an individual’s subjective satisfaction
and functioning and impairment across a number of
life domains. Disease related quality of life; on the
other hand, focuses directly on disease related
symptoms and impairment.
An evaluation of generic health related quality of
life measures in a large Australian population
sample of 834 adults33 suggests that asthma had a
adverse impact on quality of life on the physical
and mental health scale as measured by a generic
health measure the SF-12. Anxiety disorders have a
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sures.62 However, very few studies have evaluated
the impact of anxiety disorders and anxiety and
panic symptoms on asthma specific quality of life
measures in a systematic manner.
One such study63 has reported a 21% prevalence
of anxiety disorders in their sample of 136 adults
with asthma. Participants were recruited from
consecutive adult patients presenting to an asthma
clinic with a primary clinical diagnosis of asthma.
Patients with a psychiatric disorder had worse
asthma control and reported greater bronchodila-
tor use, independent of age, sex and asthma
severity. These individuals also reported worse
asthma quality of life both in general and in
relation to their symptomatology, being limited in
their daily activities, in response to environmental
stimuli, and in regard to feelings of emotional
distress. However, the psychiatric co-morbidity did
not affect forced expiratory volume in 1 s (FEV1) or
forced vital capacity (FVC) or FEV1/FVC % predicted
values significantly. Another study64 evaluated 101
patients with asthma in a clinic sample and
concluded that in these patients both illness
specific and generalized panic fears were signifi-
cantly and negatively correlated with asthma
quality of life, on an asthma specific measure, the
Living with Asthma Questionnaire (LWAQ).
Some studies have identified the impact of
anxiety symptoms on disease specific quality of life
questionnaires. An evaluation of a clinical sample
of 114 patients, with physician-diagnosed asthma
and selected from a primary care situation65
indicated that anxiety symptoms, as measured by
the HADS anxiety scores correlated negatively with
the Asthma Quality of Life Questionnaire (AQLQ)
symptom score. There was no correlation with lung
function measures. However, anxious individuals
were more likely to report respiratory symptoms.65
This could affect physician assessment of asthma
control and may result in higher prescription of
medication, some of which (short- and long-acting
beta-agonists) could worsen anxiety and adversely
influence perception of asthma symptoms. Similar
results were seen in 113 adults enrolled from an
outpatient clinic and with well-controlled asth-
ma.66 Anxiety symptoms as measured by the HADS
accounted for significant variance, and were
significantly and negatively correlated, with the
constructs of the AQLQs (LWAQ and St. George’s
Respiratory Questionnaire).
Theoretical possibilities
In addition to the effect of asthma symptoms, and
the physical limitations on quality of life, other
factors may account for deterioration in the qualityof life. Phobic avoidance of feared situations or
trigger factors and of course fear of the latter may
be excessive and lead to a vicious cycle of fear,
hyperventilation, panic and avoidance. This avoi-
dant behavior may be severely disabling and
isolating. It can become difficult for the patient
and physician to determine if the feared objects or
situations are being avoided for physiological or
psychological reasons or both. This may lead to
functional restriction much greater than objec-
tively measured physiologic level of impairment.3 It
may be speculated that this anxiety, panic and fear
avoidance can further manifest with depressive
symptoms leading to further deterioration in
quality of life. Depressive symptoms are known to
affect treatment adherence and lead to a vicious
cycle of poorer asthma control and asthma quality
of life.67 Poor asthma quality of life may be further
manifested in increased utilization of health
resources, as suggested by a large prospective
study of 1406 adult asthma patients in whom
asthma quality of life significantly predicted sub-
sequent Emergency Department utilization.68 Thus,
poor asthma quality of life has implications which
reflect and impact not only on treatment and
asthma control but also on many aspects of the
individual’s personal and social life.
It is reasonable to conclude that interventions
aimed at anxiety management which include
components targeting improved asthma quality of
life and phobic avoidance may be an important
adjunct to routine asthma management for many
patients.Treatment implications: Cognitive-
behavioral therapy (CBT)
CBT interventions are based on the premise that
the way you think affects the way you feel and the
way you behave. CBT is an effective and empirically
supported treatment of choice for anxiety disorders
and panic attacks.69 Anxiety-reducing medications
may not be the preferred mode of dealing with co-
morbid anxiety in individuals with asthma because
they do not address the root cause of the problem
and many patients prefer the choice of a non-drug
intervention. In addition some anxiolytic medica-
tions may affect ventilatory responses and interact
with concomitant medication.26,36
Some degree of anxiety about a serious illness
like asthma is adaptive, bringing expeditious action
to relieve distress.70 Conversely, low illness focused
anxiety may reduce symptom perception or inter-
pretation, so that patients may minimize their
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medication or delay use of symptom relievers. A
coping style associated with denial of the illness is
unfavorable to good asthma management.
However, as already indicated, research supports
the view that asthma is associated with an
increased prevalence of anxiety disorders; particu-
larly panic disorder and panic attacks, and also
anxiety symptoms and panic fears. Co-morbid
anxiety results in poorer asthma outcome on
various measures including asthma quality of
life.18,30 Therefore, anxiety management with due
consideration to the above-mentioned caveats,
could be an essential component of asthma
management, in patients where anxiety is a co-
morbidity and where it significantly impacts asthma
outcome.
A Cochrane review71 of psychological interven-
tions for adults with asthma has evaluated 14
randomized controlled trials of varied psychologi-
cal interventions for adults with asthma. These
reviewers highlighted the poor methodological
quality and the poor sample size as also the
diversity of interventions and outcomes. Only three
of these studies20,72,73 used a comprehensive CBT
intervention. A meta-analysis of two20,73 of these
studies indicated an improvement in asthma quality
of life. The intervention group also demonstrated a
reduction in anxiety traits or symptoms. Another
case control trial74 that used a comprehensive CBT
intervention also reported a significant decrease in
anxiety and improvement in asthma quality of life.
However, none of these studies except the most
recent by Ross et al.20 has evaluated a sample of
participants with co-morbid asthma and clinical
anxiety manifestations. Given the dearth of re-
search and the limited number of rigorous CBT
trials as well as the diversity of asthma outcomes,
we echo the concerns of the Cochrane reviewers for
larger RCTs with common interventions, taxonomy
and outcome indicators.Implications for future research: can CBT
interventions targeting co-morbid clinical
anxiety manifestations and asthma improve
asthma quality of life?
Rigorous CBT trials that involve participants with
comorbid clinical anxiety manifestations and asth-
ma are urgently needed. However , it is possible
that standard CBT protocols for anxiety and panic
should be specifically tailored and modified for
patients with asthma and26 and targeted at
improving asthma quality of life.Phobic avoidance of feared situations or trigger
factors, and of course fear of the latter, may lead
to a vicious cycle of fear, hyperventilation, panic
and avoidance. This avoidant behavior can affect
asthma quality of life and asthma control.
Standard anxiety reduction techniques depend
on gradual or graded exposure to external anxiety
causing stimuli. The anxiety stimuli are gradually
increased in intensity in a hierarchical order
(systematic desensitization and graded exposure).
However, in patients with asthma the external
anxiety-causing stimuli may include asthma trig-
gers, which have both the potential to cause
anxiety and directly cause real asthma worsening.
Patients with asthma may or may not benefit
from behavioral components like systematic sensi-
tization or graded exposure to asthma triggers.
How should asthma triggers be used to help reduce
panic? Is exposure to asthma triggers necessary?5 It
may be important for standard anxiety reducing
CBT interventions to be modified to target asthma
related avoidance behaviors and fear of asthma
triggers through a problem solving module and
appropriate use of asthma medication and the
Asthma Action Plan. This could have a positive
impact on asthma specific quality-of-life measures
but has never been adequately tested.
Secondly, the central component in the standard
CBT treatment of panic attacks is exposure to
internal physiological sensations (interoceptive
exposure) that are associated with anxiety and
panic. Fear of dyspnea may be central to panic
attacks in patients with asthma. Interoceptive
exposure habituating patients to dyspnea symp-
toms may have to be substituted by objective
monitoring and strategies like the Asthma Action
Plan, to deal with an asthma attack. Anxiety
reduction techniques in individuals with asthma
would have to be necessarily associated with
appropriate asthma monitoring and with focus on
symptom perception. Skills differentiating asthma
and anxiety symptoms may remain an important
component of the intervention.Conclusions
Asthma research literature is lacking in controlled
treatment outcome studies applying CBT to pa-
tients with co-morbid asthma and clinical anxiety
manifestations.75 Randomized controlled trials
evaluating CBT interventions, in individuals with
co-morbid asthma and clinical anxiety manifesta-
tions or a diagnosed anxiety disorder, may provide
evidence of these interventions as an effective
adjunct to improve asthma quality of life.
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